• Return to Headlines

Karyopharm Thera Has Returned 23.5% Since SmarTrend Recommendation (KPTI)

By David Diaz

SmarTrend identified an Uptrend for Karyopharm Thera (NASDAQ:KPTI) on April 16th, 2018 at $14.01. In approximately 2 months, Karyopharm Thera has returned 23.53% as of today's recent price of $17.30.

In the past 52 weeks, shares of Karyopharm Thera have traded between a low of $6.27 and a high of $20.39 and are now at $17.30, which is 176% above that low price. Over the past week, the 200-day moving average (MA) has gone up 1.0% while the 50-day MA has advanced 1.6%.

Karyopharm Therapeutics, Inc. provides biopharmaceutical products and services. The Company develops and discovers drugs for the treatment of cancer, inflammation, and diseases related to cell proliferation through activity modulation of critical pathways. Karyopham Therapeutics serves the healthcare industry throughout the United States and Germany.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Karyopharm Thera shares.

Log in and add Karyopharm Thera (KPTI) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights karyopharm thera

Ticker(s): KPTI